Literature DB >> 16287464

Changes in bladder nerve-growth factor and p75 genetic expression in streptozotocin-induced diabetic rats.

Yat-Ching Tong1, Juei-Tang Cheng.   

Abstract

OBJECTIVE: To assess changes associated with diabetes in urinary bladder nerve-growth factor (NGF) and NGF receptor p75NTR expression using a streptozotocin (STZ)-induced diabetic rat model.
MATERIALS AND METHODS: Male Wistar rats (32) were divided into four equal groups: group I, vehicle-treated normal rats; group II, vehicle-treated 9-week STZ-diabetic rats; group III, insulin-treated 9-week STZ-diabetic rats; group IV, phlorizin-treated 9-week STZ-diabetic rats. Bladder NGF levels were measured by enzyme-linked immunosorbent assay. Expressions of the mRNAs that encoded NGF and NGF receptor p75NTR in the rat bladder were evaluated using reverse transcription-polymerase chain reaction.
RESULTS: The mean (SEM) NGF level in the STZ-diabetic rat bladder was significantly lower than in the control group, at 56.56 (8.28) and 84.33 (11.05) pg/microg protein, respectively (P < 0.01). The mRNA expressions of bladder NGF and p75NTR in the diabetic rats were significantly lower than in the control group (P < 0.05 and <0.001, respectively). Treatment with either insulin or phlorizin restored the normal blood sugar level; moreover, the bladder NGF levels and the expressions of both NGF and p75NTR mRNAs were normal.
CONCLUSION: The decrease in the genetic expression of NGF and p75NTR might be responsible for the pathogenesis of diabetic cystopathy while hyperglycaemia is part of the cause of these changes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287464     DOI: 10.1111/j.1464-410X.2005.05854.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  9 in total

Review 1.  Research Findings on Overactive Bladder.

Authors:  Phani B Patra; Sayani Patra
Journal:  Curr Urol       Date:  2015-05-20

2.  Therapeutic effects of a soluble guanylate cyclase activator, BAY 60-2770, on lower urinary tract dysfunction in mice with spinal cord injury.

Authors:  Daisuke Gotoh; Tetsuichi Saito; Sergei Karnup; Yosuke Morizawa; Shunta Hori; Yasushi Nakai; Makito Miyake; Kazumasa Torimoto; Kiyohide Fujimoto; Naoki Yoshimura
Journal:  Am J Physiol Renal Physiol       Date:  2022-08-11

Review 3.  Potential role of oxidative stress in the pathogenesis of diabetic bladder dysfunction.

Authors:  Qi-Xiang Song; Yi Sun; Kangli Deng; Jin-Yi Mei; Christopher J Chermansky; Margot S Damaser
Journal:  Nat Rev Urol       Date:  2022-08-16       Impact factor: 16.430

Review 4.  Established and emerging treatments for diabetes-associated lower urinary tract dysfunction.

Authors:  Betül R Erdogan; Guiming Liu; Ebru Arioglu-Inan; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-05-12       Impact factor: 3.195

5.  Spatio-temporal analysis of type 2 diabetes mellitus based on differential expression networks.

Authors:  Shao-Yan Sun; Zhi-Ping Liu; Tao Zeng; Yong Wang; Luonan Chen
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 6.  New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors.

Authors:  Prabhakar Busa; Yaswanth Kuthati; Niancih Huang; Chih-Shung Wong
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

7.  Functional and molecular characterization of hyposensitive underactive bladder tissue and urine in streptozotocin-induced diabetic rat.

Authors:  Jayabalan Nirmal; Pradeep Tyagi; Yao-Chi Chuang; Wei-Chia Lee; Naoki Yoshimura; Chao-Cheng Huang; Bharathi Rajaganapathy; Michael B Chancellor
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

8.  Improvement in bladder dysfunction after bladder transplantation of amniotic fluid stem cells in diabetic rats.

Authors:  Ching-Chung Liang; Sheng-Wen Steven Shaw; Yung-Hsin Huang; Yi-Hao Lin; Tsong-Hai Lee
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

9.  Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study.

Authors:  Hoon Choi; Jae Hyun Bae; Cheol Young Oh; Seong Jin Jeong; Woo Jin Ko; Jong Bo Choi; Ju Tae Seo; Dong Hwan Lee; Joon Chul Kim; Kwang Woo Lee; Young Ho Kim
Journal:  Int Neurourol J       Date:  2018-03-31       Impact factor: 2.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.